Paper17512814
Sialylation of cell surface glycoconjugates is essential for osteoclastogenesis.
Takahata M and 7 others. Bone, 2007. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Sialylation of cell surface glycoconjugates is essential for osteoclastogenesis. Papers, record 17512814. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17512814
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glycoconjugates | Major topic |
| Osteoclasts | Major topic |
| Sialic Acids | Major topic |
| Animals | |
| Base Sequence | |
| Cell Differentiation | |
| Cell Fusion | |
| Cell Line | |
| Cell Membrane | |
| Cells, Cultured | |
| DNA Primers | |
| Glycolipids | |
| In Vitro Techniques | |
| Male | |
| Mice | |
| Osteogenesis | |
| RNA, Small Interfering | |
| Sialoglycoproteins | |
| Sialyltransferases | |
| Stem Cells | |
| beta-D-Galactoside alpha 2-6-Sialyltransferase |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41680135 | Estradiol regulates osteoclast sialylation via ST3Gal1 in postmenopausal osteoporosis. | Bone Res | 2026 | https://conductscience.org/library/papers/41680135 | PubMed |
| 41356197 | Fibroblast-derived NEU1 as a therapeutic target for improving cortical bone integrity and fracture healing. | Theranostics | 2026 | https://conductscience.org/library/papers/41356197 | PubMed |
| 39609348 | Comprehensive Analysis of Sialylation-Related Gene Profiles and Their Impact on the Immune Microenvironment in Periodontitis. | Inflammation | 2025 | https://conductscience.org/library/papers/39609348 | PubMed |
| 39596031 | Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596031 | PubMed |
| 38612379 | Regulation of Glycosylation in Bone Metabolism. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612379 | PubMed |
| 38328161 | COLLAGEN MINERALIZATION DECREASES NK CELL-MEDIATED CYTOTOXICITY OF BREAST CANCER CELLS VIA INCREASED GLYCOCALYX THICKNESS. | bioRxiv | 2024 | https://conductscience.org/library/papers/38328161 | PubMed |
| 38279892 | Collagen Mineralization Decreases NK Cell-Mediated Cytotoxicity of Breast Cancer Cells via Increased Glycocalyx Thickness. | Adv Mater | 2024 | https://conductscience.org/library/papers/38279892 | PubMed |
| 37884496 | Glycobiology in osteoclast differentiation and function. | Bone Res | 2023 | https://conductscience.org/library/papers/37884496 | PubMed |
| 37843557 | Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37843557 | PubMed |
| 36377513 | An insight into new glycotherapeutics in glial inflammation: Understanding the role of glycosylation in mitochondrial function and acute to the chronic phases of inflammation. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/36377513 | PubMed |
| 35232979 | Sialylation of TLR2 initiates osteoclast fusion. | Bone Res | 2022 | https://conductscience.org/library/papers/35232979 | PubMed |
| 34817551 | DCIR and its ligand asialo-biantennary N-glycan regulate DC function and osteoclastogenesis. | J Exp Med | 2021 | https://conductscience.org/library/papers/34817551 | PubMed |
| 34732696 | Engineered osteoclasts as living treatment materials for heterotopic ossification therapy. | Nat Commun | 2021 | https://conductscience.org/library/papers/34732696 | PubMed |
| 31900164 | Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases. | J Biomed Sci | 2020 | https://conductscience.org/library/papers/31900164 | PubMed |
| 28884667 | Influenza virus replication in macrophages: balancing protection and pathogenesis. | J Gen Virol | 2017 | https://conductscience.org/library/papers/28884667 | PubMed |
| 28326343 | N-acetylglucosamine suppresses osteoclastogenesis in part through the promotion of O-GlcNAcylation. | Bone Rep | 2016 | https://conductscience.org/library/papers/28326343 | PubMed |
| 25023003 | Novel candidate genes putatively involved in stress fracture predisposition detected by whole-exome sequencing. | Genet Res (Camb) | 2014 | https://conductscience.org/library/papers/25023003 | PubMed |
| 24446437 | Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24446437 | PubMed |
| 22451653 | Siglec-15 protein regulates formation of functional osteoclasts in concert with DNAX-activating protein of 12 kDa (DAP12). | J Biol Chem | 2012 | https://conductscience.org/library/papers/22451653 | PubMed |
| 21945356 | RNA therapeutics targeting osteoclast-mediated excessive bone resorption. | Adv Drug Deliv Rev | 2012 | https://conductscience.org/library/papers/21945356 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17512814
GET https://conductscience.org/api/papers/v1/17512814/cited_by?page=2